A small clinical trial has found that every single rectal cancer patient who received an experimental treatment found that their cancer had vanished. Full story on Dynamite News:
A new study at the University Of Washington School Of Medicine said that patients treated for Merkel cell carcinoma (MCC) face a 40 per cent of recurrence rate in five years.
English
English
English
